Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double blind crossover comparison of diuretics in young patients with low-renin hypertension
2006-000637-35Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bendroflumethiazide, amiloride, furosemide and spironolactone in hypertension (HTN), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Optimal diuretic for blood pressure control in low-renin hypertension. Started May 2006; status: completed.
02
Drugs
bendroflumethiazideamiloridefurosemidespironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-000637-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000637-35.